Xiang‐Nan Jiang

ORCID: 0000-0001-5079-4783
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lymphoma Diagnosis and Treatment
  • Viral-associated cancers and disorders
  • CNS Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Chronic Lymphocytic Leukemia Research
  • Ovarian cancer diagnosis and treatment
  • Anesthesia and Pain Management
  • Sarcoma Diagnosis and Treatment
  • Cutaneous lymphoproliferative disorders research
  • Head and Neck Cancer Studies
  • Lung Cancer Research Studies
  • Molecular Biology Techniques and Applications
  • Ferroptosis and cancer prognosis
  • Histiocytic Disorders and Treatments
  • Virus-based gene therapy research
  • RNA modifications and cancer
  • Gastric Cancer Management and Outcomes
  • Gastroesophageal reflux and treatments
  • HER2/EGFR in Cancer Research
  • Pancreatic and Hepatic Oncology Research
  • Wnt/β-catenin signaling in development and cancer
  • Gastrointestinal Tumor Research and Treatment
  • Inflammatory Biomarkers in Disease Prognosis

Fudan University Shanghai Cancer Center
2015-2025

Wenzhou Medical University
2024

Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University
2024

Shanghai Medical College of Fudan University
2001-2023

Fudan University
2023

The First Affiliated Hospital, Sun Yat-sen University
2001

Zhongshan Hospital
2001

Sun Yat-sen University
2001

Primary liver tumors (PLCs) and metastasis currently represent the leading cause of cancer-related deaths worldwide due to poor outcomes, high incidence, postsurgical recurrence. Hence, novel diagnostic markers therapeutic strategies for PLCs are urgently needed. The human microbiome can directly or indirectly impact cancer initiation, progression, response therapy, including immunotherapy; however, roles microbiota in tumor microenvironment not clear require more investigation. Here, we...

10.1002/hep4.1908 article EN cc-by-nc-nd Hepatology Communications 2022-02-22

Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) is a highly aggressive malignancy with inferior outcomes after treatment, which might be largely attributed to the immune escape induced by EBV via modulation of checkpoint programmed cell death 1 (PD-1)/PD-ligand (PD-L1). This study aimed explore role that EBV-encoded latent membrane protein 2A (LMP2A) played in mechanisms EBV+ DLBCL cells. Ten cases each and without immunohistochemical expression LMP2A were submitted...

10.1016/j.labinv.2025.104104 article EN cc-by-nc-nd Laboratory Investigation 2025-02-01

EBV + inflammatory follicular dendritic cell (FDC) sarcoma is an indolent malignant neoplasm of spindled FDCs with a rich lymphoplasmacytic infiltrate and consistent association Epstein-Barr virus (EBV). It occurs exclusively in the liver spleen, exception few colonic examples. In this study, we report 9 extrahepatosplenic cases, including 4 occurring previously undescribed sites, but all apparently anatomically related to aerodigestive tract. The cases included 5 gastrointestinal tumors...

10.1097/pas.0000000000001632 article EN The American Journal of Surgical Pathology 2020-12-01

Abstract Purpose Large B‐cell lymphoma with IRF4 rearrangement (LBCL, +) has been recently recognized as a specific entity that is frequently associated young age and favorable prognosis. However, whether the good outcome of disease due to + or other factors remains obscure. We thus analyzed 100 patients primary head neck LBCL see clinicopathologic correlates +. Methods The histopathology, immunophenotype, status tumors, clinical data were reviewed. Results Twenty‐one tumors diagnosed LBCL,...

10.1002/cam4.5828 article EN cc-by Cancer Medicine 2023-04-20

The well-established cell-of-origin (COO) algorithm categorizes diffuse large B-cell lymphoma (DLBCL) into activated B-cell-like (ABC) and germinal center (GCB) subgroups through gene expression profiling. We aimed to develop validate a qPCR-based assay determine the COO of DLBCL with formalin-fixed paraffin-embedded (FFPE) tissue. first established transcriptome database 1,016 samples retrieved from three published datasets (GSE10846, GSE22470, GSE31312). With this database, we identified...

10.3389/fonc.2020.00803 article EN cc-by Frontiers in Oncology 2020-06-05

Pediatric-type follicular lymphoma (PTFL) is a rare pediatric-type indolent B-cell that clinicopathologically differs from adult lymphoma. Accurate diagnosis of PTFL, which often challenging, essential to avoid missed diagnosis, misdiagnosis, and overtreatment. To improve our understanding clinicopathological features, differential molecular mutation characteristics four patients PTFL were analyzed using hematoxylin eosin staining, immunohistochemistry, polymerase chain reaction,...

10.3389/fped.2023.1205384 article EN cc-by Frontiers in Pediatrics 2023-07-19

DIXDC1 (Dishevelled-Axin domain containing 1) is a positive regulator of the Wnt pathway. In field cancer research, role unclear. Our previous in vitro study showed that enhances β-catenin nuclear accumulation gastric cell lines. The aim this was to detect expression different histological subtypes carcinoma and evaluate correlation between localization clinicopathological parameters, including patients' survival.Immunohistochemical staining performed characterize archived materials from 259...

10.1186/s12935-015-0273-2 article EN cc-by Cancer Cell International 2015-12-01

Abstract The prognostic value of histologic grading and the Ki‐67 proliferation index in follicular lymphoma (FL) is controversial. This study investigated clinical usefulness these two factors Asian FL patients. Four hundred thirty‐three patients diagnosed with were retrospectively reviewed a median follow‐up time 47.0 months (range, 24.0‐168.0). 10‐year overall survival (OS) rate progression‐free (PFS) 91.0% 47.1%, respectively. Grade 3B grade diffuse large B cell (DLBCL) showed better PFS...

10.1002/hon.2778 article EN Hematological Oncology 2020-07-06

MYC overexpression is a common feature of diffuse large B-cell lymphoma (DLBCL) and associated with poor prognosis in patients this neoplasm. We aimed to investigate the underlying mechanisms dysregulation, as they have not been fully determined.We immunohistochemically evaluated correlation between receptor (BCR)-phosphoinositide 3-kinase (PI3K) pathway activity level 108 cases de-novo DLBCL, 25 which featured loss BCR, investigated effects BCR-PI3K signalling on phosphorylation DLBCL cell...

10.1111/his.13287 article EN Histopathology 2017-06-22

To investigate the efficacy and safety of bupivacaine liposome for pericapsular nerve group block (PENGB) postoperative analgesia in elderly patients with total hip replacement.

10.3760/cma.j.cn112137-20230810-00190 article EN PubMed 2024-01-16

Recent studies have demonstrated the benefits of metformin on patients with lymphomas. B-cell receptor (BCR)-PI3K-AKT pathway-dependent cholesterol synthesis may represent a positive feedback mechanism responsible for pathogenesis BCR-dependent diffuse large lymphomas (DLBCLs). Thus, restriction lipid would affect integrity lipid-forming membranes and block BCR signaling pathway. Our in vitro findings suggested that blocking effect pathway is possibly exerted via biosynthesis cholesterol. A...

10.3389/fonc.2021.608238 article EN cc-by Frontiers in Oncology 2021-06-14

Aims Programmed death-ligand 1 (PD-L1) is known to be highly expressed in various malignancies, including head and neck squamous cell carcinoma (HNSCC). We aimed determine the prevalence of PD-L1 expression recurrent or metastatic HNSCC (R/M HNSCC) among Chinese patients. Methods This multicentre, retrospective analysis data from six centres China included patients with R/M treated 9 August 2021 28 February 2022. tumour tissue was assessed represented using a combined positive score (CPS)....

10.1136/jcp-2023-209059 article EN cc-by-nc Journal of Clinical Pathology 2023-11-15

Objective: To investigate the clinical pathological features, diagnosis and differential of hybrid schwannoma/perineurioma. Methods: The clinicopathological data 35 cases were collected at Fudan University Shanghai Cancer Center, from October 2010 to August 2017; morphological observation immunohistochemical staining performed, literatures also reviewed. Results: There 7 males 28 females (male∶female=1∶4), patients with onset age ranging 3 81 years(mean=36 years). Of tumors, 11 occurred in...

10.3760/cma.j.issn.0529-5807.2019.09.005 article EN PubMed 2019-09-08

Pediatric-type follicular lymphoma (PTFL) and pediatric nodal marginal zone (PNMZL) are two rare indolent B-cell lymphomas with overlapping features. Recently, cases showing hybridizing features of PTFL PNMZL have been reported. Herein, we retrospectively analyzed the clinicopathologic 59 patients, including 39 PTFL, 5 PNMZL, 15 mixed-type tumors (MTT). And next-generation sequencing analysis was performed on 3 2 MTT cases. In addition, previously published mutational data 96 PTFLs, 25...

10.1007/s00428-024-03941-2 article EN cc-by-nc-nd Virchows Archiv 2024-10-08

Diffuse Large B-Cell Lymphoma (DLBCL) is the most common lymphoid malignancy in adults, which often takes a nonlymph nodes organ as primary focus. Primary of thyroid gland not clinic, EBV-positive diffuse large B-cell lymphoma rare and its pathogenesis, treatment prognosis are rarely studied. We reported an 85-year-old female patient with gland, disease eventually relapsed skeletal muscle patient. The pathological type after relapse was consistent that As far we know secondary DLBCL from...

10.26420/austinjmedoncol.2021.1057 article EN Austin Journal of Medical Oncology 2021-01-18

Pediatric follicular lymphoma (PTFL) is one of the rare pediatric-type indolent B-cell lymphomas that clinicopathologically differs from adult lymphoma. Accurate diagnosis PTFL essential to avoid leak-diagnosis, misdiagnosis and overtreatment, but it often challenging. To improve understanding PTFL, we collected four cases analyzed clinicopathological features, differential molecular mutation characteristics by hematoxylin‑eosin stain, immunohistochemistry, polymerase chain reaction (PCR),...

10.22541/au.167845648.82400600/v1 preprint EN Authorea (Authorea) 2023-03-10

Abstract Programmed death-ligand 1 (PD-L1) is a trans-membrane protein and co-inhibitory factor of the immune response. PD-L1 can combine with its receptor (PD-1) to reduce proliferation PD-1-positive cells induce apoptosis. Therefore, was employed as prognostic marker target for anti-cancer immunotherapy in blocking PD-1 checkpoints. highly expressed various malignancies, including head neck squamous cell carcinoma (HNSCC). HNSCC sixth most common cancer worldwide, high incidence mortality...

10.1158/1538-7445.am2023-5463 article EN Cancer Research 2023-04-04

Background: Anaplastic lymphoma kinase-positive large B-cell (ALK+ LBCL) is a rare neoplasm of B-cells with plasmablastic immunophenotype and ALK expression due to rearrangements. The molecular genetic profile the disease, however, remains largely unknown. Design: Clinicopathologic features 10 cases ALK+ LBCL 12 ALK-negative were retrospectively analyzed. mutational landscapes revealed by screening targeted panel 136 genes using next-generation sequencing formalin-fixed, paraffin-embedded...

10.1002/hon.3165_469 article EN Hematological Oncology 2023-06-01

Background: Human epidermal growth factor receptor 2 (HER2) is crucial for the development and targeted therapy of gastric carcinoma. GC highly heterogeneous. In current clinical practice, however, accurate assessment HER2 status cannot be achieved in surgical specimens. Methods: All formalin-fixed paraffin-embedded (FFPE) samples 2627 surgically resected specimens carcinoma were analyzed with immunohistochemistry (IHC) methods. Based on Monte Carlo method MATLAB software, 3+ positivity rate...

10.2139/ssrn.4667606 preprint EN 2023-01-01

Background: EBV+ DLBCL is an aggressive malignancy that largely resistant to current therapeutic regimens. LMP2A expressed during different latency stages of EBV-infected B cells in which it triggers activation cytoplasmic protein tyrosine kinases. Early studies have revealed immunoreceptor tyrosine-based motif the N-terminus can trigger a transient increase cytosolic Ca2+ concentration similar observed activated cells. Meanwhile, tumor often express PD-L1 DLBCL, providing possible mechanism...

10.1002/hon.22_2631 article EN Hematological Oncology 2019-06-01

Background: B-cells can function as antigen presenting cells by antigens captured the B-cell receptor (BCR) on Class II Major Histocompatibility Complex (MHCII) to T-cells. In addition, also maintain immune homeostasis expressing PD-L1 and suppress T-cell activity. Epstein-Barr virus (EBV) infection disrupt lead malignancies, including diffuse large lymphoma (DLBCL). Here we show that EBV-positive DLBCL (EBV+ DLBCL) has decreased BCR MHCII expression, but over-expressed PD-L1, which may...

10.1002/hon.21_2631 article EN Hematological Oncology 2019-06-01
Coming Soon ...